These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 30356024)

  • 1. Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics.
    Sharma C; Seo YH
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30356024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Heat Shock Factor 1 in Cancer: A Unique Therapeutic Opportunity.
    Dong B; Jaeger AM; Thiele DJ
    Trends Pharmacol Sci; 2019 Dec; 40(12):986-1005. PubMed ID: 31727393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progress.
    Kijima T; Prince T; Neckers L; Koga F; Fujii Y
    Expert Opin Ther Targets; 2019 May; 23(5):369-377. PubMed ID: 30931649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HSF1 as a Cancer Biomarker and Therapeutic Target.
    Carpenter RL; Gökmen-Polar Y
    Curr Cancer Drug Targets; 2019; 19(7):515-524. PubMed ID: 30338738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic role of HSF1 in neoplastic transformation.
    Vydra N; Toma A; Widlak W
    Curr Cancer Drug Targets; 2014; 14(2):144-55. PubMed ID: 24467529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of HSF1 Protein in Malignant Transformation.
    Šimončík O; Pastorek M; Vojtěšek B; Müller P
    Klin Onkol; 2018; 31(Suppl 2):55-62. PubMed ID: 31023025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.
    Fok JHL; Hedayat S; Zhang L; Aronson LI; Mirabella F; Pawlyn C; Bright MD; Wardell CP; Keats JJ; De Billy E; Rye CS; Chessum NEA; Jones K; Morgan GJ; Eccles SA; Workman P; Davies FE
    Clin Cancer Res; 2018 May; 24(10):2395-2407. PubMed ID: 29391353
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent advances in small molecule prodrugs for cancer therapy.
    Wang P; Jin X; Cai J; Chen J; Ji M
    Anticancer Agents Med Chem; 2014 Mar; 14(3):418-39. PubMed ID: 23869777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat Shock Proteins (HSPs): A Novel Target for Cancer Metastasis Prevention.
    Narayanankutty V; Narayanankutty A; Nair A
    Curr Drug Targets; 2019; 20(7):727-737. PubMed ID: 30526455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design and screening of peptide-based inhibitors of heat shock factor 1 (HSF1).
    Ran X; Burchfiel ET; Dong B; Rettko NJ; Dunyak BM; Shao H; Thiele DJ; Gestwicki JE
    Bioorg Med Chem; 2018 Oct; 26(19):5299-5306. PubMed ID: 29661622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of HSF1 in cells from PIK3CA-related overgrowth spectrum patients blocks abnormal proliferation.
    Da Costa R; De Almeida S; Chevarin M; Hadj-Rabia S; Leclerc-Mercier S; Thauvin-Robinet C; Garrido C; Faivre L; Vabres P; Duplomb L; Jego G
    Biochem Biophys Res Commun; 2020 Sep; 530(3):520-526. PubMed ID: 32620236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies on the development of small molecule anticancer drugs for targeted therapy.
    Lu YH; Gao XQ; Wu M; Zhang-Negrerie D; Gao Q
    Mini Rev Med Chem; 2011 Jun; 11(7):611-24. PubMed ID: 21699492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal Transducer and Activator of Transcription Protein 3 (STAT3): An Update on its Direct Inhibitors as Promising Anticancer Agents.
    Gelain A; Mori M; Meneghetti F; Villa S
    Curr Med Chem; 2019; 26(27):5165-5206. PubMed ID: 30027840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis.
    Liang W; Liao Y; Zhang J; Huang Q; Luo W; Yu J; Gong J; Zhou Y; Li X; Tang B; He S; Yang J
    J Exp Clin Cancer Res; 2017 May; 36(1):64. PubMed ID: 28482903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting the transcription factor HSF1 as an anticancer strategy.
    Whitesell L; Lindquist S
    Expert Opin Ther Targets; 2009 Apr; 13(4):469-78. PubMed ID: 19335068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Multifaceted Role of HSF1 in Tumorigenesis.
    Alasady MJ; Mendillo ML
    Adv Exp Med Biol; 2020; 1243():69-85. PubMed ID: 32297212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reflections and Outlook on Targeting HSP90, HSP70 and HSF1 in Cancer: A Personal Perspective.
    Workman P
    Adv Exp Med Biol; 2020; 1243():163-179. PubMed ID: 32297218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective killing of cancer cells by small molecules targeting heat shock stress response.
    Zhang D; Zhang B
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1509-14. PubMed ID: 27553278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway.
    Chen K; Qian W; Li J; Jiang Z; Cheng L; Yan B; Cao J; Sun L; Zhou C; Lei M; Duan W; Ma J; Ma Q; Ma Z
    Mol Oncol; 2017 Oct; 11(10):1475-1492. PubMed ID: 28783244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib-induced heat shock response protects multiple myeloma cells and is activated by heat shock factor 1 serine 326 phosphorylation.
    Shah SP; Nooka AK; Jaye DL; Bahlis NJ; Lonial S; Boise LH
    Oncotarget; 2016 Sep; 7(37):59727-59741. PubMed ID: 27487129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.